Boulder Hill Capital Management’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-11,200	Closed	-$163K	–	138
2021 Q4	$163K	Buy	+11,200	New	+$163K	0.16%	144